期刊文献+

人类免疫缺陷病毒感染者合并丙型肝炎病毒感染的危害性及治疗策略

原文传递
导出
摘要 随着高效抗逆转录病毒治疗(highly active antiretroviral therapy,HAART)在临床上的广泛开展,HIV/AIDS患者的生存时间显著延长。据估计,如果患者血浆HIV能在治疗后得到完全控制,其预期寿命能超过30~40年甚至更长。目前AIDS已成为一种像高血压或糖尿病那样无法完全根治,但可以在药物治疗下长期存活的慢性疾病。由于HIV和HCV有着相同的传播途径,即血液传播、性传播和母婴垂直传播,因此,HIV、HCV共感染情况就非常常见,随着HIV/AIDS患者在HAART后生存时间的延长,肝脏损伤对其生存质量和生存时间的影响也更加明显。
出处 《中华内科杂志》 CAS CSCD 北大核心 2009年第8期617-619,共3页 Chinese Journal of Internal Medicine
  • 相关文献

参考文献28

  • 1David L. Growing importance of liver disease in HIV-infected persons. Hepatology, 2006,43:221-229.
  • 2Rosenthal E, Poiree M, Pradier C, et al. Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study). AIDS, 2003, 17:1803-1809.
  • 3Martin-Carbonero L, Soriano V, Valencia E, et al. Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients. AIDS Res Hum Retroviruses, 2001, 17 : 1467-1471.
  • 4Bica I, McGovern B, Dhar R, et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis, 2001,32:492497.
  • 5张卫东,郗园林,张梅喜,段广才.血源性艾滋病高发村村民HIV/HBV/HCV混合感染状况调查[J].郑州大学学报(医学版),2006,41(2):254-256. 被引量:11
  • 6邵红,彭红,田永芳,杨飞.静脉吸毒人群HIV/HBV/HCV混合感染分析[J].中国公共卫生,2004,20(8):967-968. 被引量:16
  • 7吕玮,戴懿,邱志峰,许少侠,匡季秋,李雁凌,谢静,韩杨,左玲燕,刘正印,邓国华,王爱霞,李太生.经血液(非静脉吸毒者)和性途径传播的HIV感染者合并HBV和HCV感染的现状[J].中华传染病杂志,2009,27(3):147-151. 被引量:3
  • 8Thomas DL, Astemborski J, Rai RM, et al. The natural history of hepatitis C virus infection:host, viral, and environmental factors. JAMA, 2000,284:450-456.
  • 9Soriano V, Pouti M, Sulkowski M, et al. Care of patients with hepatitis C and HIV-coinfeetion. Updated recommendations from the HCV-HIV International Panel. AIDS, 2004,18 : 1-12.
  • 10Thomson EC, Nastouli E, Main J, et al. Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV. AIDS, 2009,23 : 89-93.

二级参考文献26

  • 1邵红,彭红,田永芳,杨飞.静脉吸毒人群HIV/HBV/HCV混合感染分析[J].中国公共卫生,2004,20(8):967-968. 被引量:16
  • 2病毒性肝炎防治方案(试行)[J].中华传染病杂志,1995,13(4):241-247. 被引量:1767
  • 3王佑春,许四宏,李秀华,宋爱京,贾雪荣,庄辉.静脉注射毒品人群中HIV、HBV和HCV感染的现况研究[J].中华流行病学杂志,2006,27(9):777-779. 被引量:23
  • 4何云,赵清霞,任英杰,丁丽敏.128例经血感染HIV患者合并HCV和HBV感染状况[J].中国医学科学院学报,2006,28(5):662-664. 被引量:13
  • 5Sherman KE, Pelers M, Koziel MJ. HIV and liver disease forum: conference proceedings. Hepatology, 2007,45:1566- 3577.
  • 6Brook MG, Gilson R. Wilkins EL. BHIVA Guidelines: coinfection with HIV and chronic hepatitis B virus. H1V Med. 2003,4 Suppl 1 :S42-51.
  • 7Hoffmann CJ, Thio CI.. Clinical implications of HIV and hepatitis B co infection in Asia and Africa. Lancet Infect Dis. 2007,7:402-409.
  • 8Verucchi G, Calza L, Manfredi R, et al. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management. Infection,2004,32 : 33 -46.
  • 9Sulkowski MS, Benhamou Y. Therapeutic issues in HIV/ HCV-coinfeeted patients. J Viral Hepal. 2007,14:371- 386.
  • 10Wang YM, Ng WC, Lo SK. Suppression of hepatitis C virus by hepatitis B virus in coinfected patients at the National University Hospital of Singapore. J Gastroenterol, 1999, 34,481-485.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部